A Deep Learning System Using Optical Coherence Tomography Angiography to Detect Glaucoma and Anterior Ischemic Optic Neuropathy.

anterior ischemic optic neuropathy artificial intelligence deep learning glaucoma neuronal network optical coherence tomography angiography

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
07 Jan 2023
Historique:
received: 08 11 2022
revised: 30 12 2022
accepted: 04 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 22 1 2023
Statut: epublish

Résumé

Glaucoma and non-arteritic anterior ischemic optic neuropathy (NAION) are optic neuropathies that can both lead to irreversible blindness. Several studies have compared optical coherence tomography angiography (OCTA) findings in glaucoma and NAION in the presence of similar functional and structural damages with contradictory results. The goal of this study was to use a deep learning system to differentiate OCTA in glaucoma and NAION. Sixty eyes with glaucoma (including primary open angle glaucoma, angle-closure glaucoma, normal tension glaucoma, pigmentary glaucoma, pseudoexfoliative glaucoma and juvenile glaucoma), thirty eyes with atrophic NAION and forty control eyes (NC) were included. All patients underwent OCTA imaging and automatic segmentation was used to analyze the macular superficial capillary plexus (SCP) and the radial peripapillary capillary (RPC) plexus. We used the classic convolutional neural network (CNN) architecture of ResNet50. Attribution maps were obtained using the "Integrated Gradients" method. The best performances were obtained with the SCP + RPC model achieving a mean area under the receiver operating characteristics curve (ROC AUC) of 0.94 (95% CI 0.92-0.96) for glaucoma, 0.90 (95% CI 0.86-0.94) for NAION and 0.96 (95% CI 0.96-0.97) for NC. This study shows that deep learning architecture can classify NAION, glaucoma and normal OCTA images with a good diagnostic performance and may outperform the specialist assessment.

Identifiants

pubmed: 36675435
pii: jcm12020507
doi: 10.3390/jcm12020507
pmc: PMC9865592
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Br J Ophthalmol. 2022 Sep;106(9):1245-1251
pubmed: 33827858
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5993-5999
pubmed: 29183045
Arch Ophthalmol. 2003 May;121(5):643-50
pubmed: 12742841
J Glaucoma. 2021 Jun 1;30(6):465-472
pubmed: 33675336
J Ophthalmol. 2016;2016:6956717
pubmed: 26998352
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3350-3356
pubmed: 28687846
Retina. 2016 Dec;36 Suppl 1:S168-S177
pubmed: 28005675
Curr Eye Res. 2018 Jun;43(6):778-784
pubmed: 29451992
J Neuroophthalmol. 2019 Sep;39(3):339-344
pubmed: 30893268
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Neuroophthalmology. 2017 Jan 27;41(2):76-83
pubmed: 28348629
Am J Ophthalmol. 2014 Dec;158(6):1121-1129.e1
pubmed: 25152501
J Glaucoma. 2017 May;26(5):466-472
pubmed: 28234681
Br J Ophthalmol. 2016 May;100(5):671-6
pubmed: 26377414
Am J Ophthalmol. 2020 Mar;211:123-131
pubmed: 31730838
Lancet Digit Health. 2021 Mar;3(3):e195-e203
pubmed: 33478929
Int J Mol Sci. 2021 Apr 28;22(9):
pubmed: 33925045
Biomed Res Int. 2017;2017:3079141
pubmed: 29392131
Ophthalmology. 1986 Mar;93(3):357-61
pubmed: 3703503
PLoS One. 2018 Jan 10;13(1):e0189237
pubmed: 29320503
J Fr Ophtalmol. 2020 Feb;43(2):e41-e54
pubmed: 31952875
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):870-877
pubmed: 29490340
Curr Eye Res. 2017 Sep;42(9):1313-1318
pubmed: 28557580
J Glaucoma. 2020 Jun;29(6):492-497
pubmed: 32205832
Exp Eye Res. 2014 Dec;129:83-92
pubmed: 25447563
Am J Ophthalmol. 2020 Jan;209:27-34
pubmed: 31562857
Am J Ophthalmol. 2017 Oct;182:107-117
pubmed: 28734815
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6265-6270
pubmed: 27849312
Br J Ophthalmol. 2002 Feb;86(2):238-42
pubmed: 11815354
PLoS One. 2017 Sep 21;12(9):e0184948
pubmed: 28934255
J Neuroophthalmol. 2017 Jun;37(2):140-148
pubmed: 27984351
Graefes Arch Clin Exp Ophthalmol. 2021 Jul;259(7):1945-1953
pubmed: 33661365
Graefes Arch Clin Exp Ophthalmol. 2016 Jun;254(6):1051-8
pubmed: 26338819
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT486-94
pubmed: 27442342
Lancet Glob Health. 2021 Feb;9(2):e144-e160
pubmed: 33275949
Transl Vis Sci Technol. 2020 Oct 15;9(2):55
pubmed: 33117612
J Ophthalmol. 2019 Jan 15;2019:7419470
pubmed: 30766730
PLoS One. 2016 Apr 01;11(4):e0150242
pubmed: 27035660
Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):42
pubmed: 33635311
J Ophthalmol. 2017;2017:9632647
pubmed: 28316838
Ophthalmology. 2021 Aug;128(8):1222-1235
pubmed: 33632585

Auteurs

Roxane Bunod (R)

Department of Ophthalmology 3, Quinze-Vingts National Ophthalmology Hospital, 28 Rue de Charenton, 75012 Paris, France.

Mélanie Lubrano (M)

Keen Eye Technologies SAS, 74 Rue du Faubourg Saint-Antoine, 75012 Paris, France.

Antoine Pirovano (A)

Keen Eye Technologies SAS, 74 Rue du Faubourg Saint-Antoine, 75012 Paris, France.

Géraldine Chotard (G)

Department of Ophthalmology 4, Quinze-Vingts National Ophthalmology Hospital, 28 Rue de Charenton, 75012 Paris, France.

Emmanuelle Brasnu (E)

Department of Ophthalmology 3, Quinze-Vingts National Ophthalmology Hospital, 28 Rue de Charenton, 75012 Paris, France.

Sylvain Berlemont (S)

Keen Eye Technologies SAS, 74 Rue du Faubourg Saint-Antoine, 75012 Paris, France.

Antoine Labbé (A)

Department of Ophthalmology 3, Quinze-Vingts National Ophthalmology Hospital, 28 Rue de Charenton, 75012 Paris, France.
IHU FOReSIGHT, INSERM-DGOS CIC 1423, 17 Rue Moreau, 75012 Paris, France.
INSERM, CNRS, Institut de la Vision, Sorbonne Universités, 7 Rue Moreau, 75012 Paris, France.
Department of Ophthalmology, Ambroise Paré Hospital, IHU FOReSIGHT, AP-HP, University of Paris Saclay, 9 Avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France.

Edouard Augstburger (E)

Department of Ophthalmology 3, Quinze-Vingts National Ophthalmology Hospital, 28 Rue de Charenton, 75012 Paris, France.

Christophe Baudouin (C)

Department of Ophthalmology 3, Quinze-Vingts National Ophthalmology Hospital, 28 Rue de Charenton, 75012 Paris, France.
IHU FOReSIGHT, INSERM-DGOS CIC 1423, 17 Rue Moreau, 75012 Paris, France.
INSERM, CNRS, Institut de la Vision, Sorbonne Universités, 7 Rue Moreau, 75012 Paris, France.
Department of Ophthalmology, Ambroise Paré Hospital, IHU FOReSIGHT, AP-HP, University of Paris Saclay, 9 Avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France.

Classifications MeSH